Exosomes contribution in COVID-19 patients' treatment

L Mazini, L Rochette, G Malka - Journal of Translational Medicine, 2021 - Springer
Adipose cell-free derivatives have been recently gaining attention as potential therapeutic
agents for various human diseases. In this context, mesenchymal stromal/stem cells (MSCs) …

Exosomes in COVID‐19 infection: Focus on role in diagnosis, pathogenesis, immunity, and clinical trials

A Aljuhani, O Albalawi, R Albalawi… - Cell Biology …, 2023 - Wiley Online Library
Since the end of 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
spread as a new strain of coronavirus disease (COVID‐19) and progressed as a global …

Mesenchymal stem cell-derived exosomes exhibit promising potential for treating SARS-CoV-2-infected patients

A Raghav, ZA Khan, VK Upadhayay, P Tripathi… - Cells, 2021 - mdpi.com
The novel coronavirus severe acute respiratory syndrome-CoV-2 (SARS-CoV-2) is
responsible for COVID-19 infection. The COVID-19 pandemic represents one of the worst …

Exosomes and COVID-19: challenges and opportunities

G Babaei, N Zare, A Mihanfar, MHK Ansari - Comparative Clinical …, 2022 - Springer
Abstract Coronavirus disease 2019 or COVID-19, starting from Wuhan, China, in December
2019, is a pandemic situation affecting millions worldwide and has exerted a huge burden …

Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia

A Akbari, J Rezaie - Stem cell research & therapy, 2020 - Springer
Background The outbreak of a new virus known as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has now become the main health concern all over the world …

Exosomes, and the potential for exosome‐based interventions against COVID‐19

A Rahmani, A Soleymani, M Almukhtar… - Reviews in Medical …, 2024 - Wiley Online Library
Since late 2019, the world has been devastated by the coronavirus disease 2019 (COVID‐
19) induced by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), with more …

Extracellular vesicles as a translational approach for the treatment of COVID-19 disease: an updated overview

E Serretiello, A Ballini, A Smimmo, M Acunzo, M Raimo… - Viruses, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic
in the years 2020–2022. With a high prevalence, an easy route of transmission, and a long …

The impact understanding of exosome therapy in COVID-19 and preparations for the future approaches in dealing with infectious diseases and inflammation

Z Nasiri, H Soleimanjahi, N Baheiraei, SM Hashemi… - Scientific Reports, 2024 - nature.com
Cytokine storms, which result from an abrupt, acute surge in the circulating levels of different
pro-inflammatory cytokines, are one of the complications associated with severe acute …

Shedding lights on the extracellular vesicles as functional mediator and therapeutic decoy for COVID-19

A Thakur - Life, 2023 - mdpi.com
COVID-19 is an infectious disease caused by the novel coronavirus (SARS-CoV-2) that first
appeared in late 2019 and has since spread across the world. It is characterized by …

Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises

L Rezakhani, AF Kelishadrokhi… - Chemistry and physics …, 2021 - Elsevier
There are no commercially available effective antiviral medications or vaccines to deal with
novel coronavirus disease (COVID-19). Hence there is a substantial unmet medical need for …